FI52859C - Menetelmä matolääkkeinä vaikuttavien 5-(substituoitu amino)-bentsimida tsolien valmistamiseksi. - Google Patents

Menetelmä matolääkkeinä vaikuttavien 5-(substituoitu amino)-bentsimida tsolien valmistamiseksi.

Info

Publication number
FI52859C
FI52859C FI680234A FI23468A FI52859C FI 52859 C FI52859 C FI 52859C FI 680234 A FI680234 A FI 680234A FI 23468 A FI23468 A FI 23468A FI 52859 C FI52859 C FI 52859C
Authority
FI
Finland
Prior art keywords
anthelmintics
benzimidazoles
acting
preparation
substituted amino
Prior art date
Application number
FI680234A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI52859B (enExample
Inventor
Michael Herbert Fisher
Dale Richard Hoff
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI52859B publication Critical patent/FI52859B/fi
Application granted granted Critical
Publication of FI52859C publication Critical patent/FI52859C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • E—FIXED CONSTRUCTIONS
    • E21—EARTH OR ROCK DRILLING; MINING
    • E21D—SHAFTS; TUNNELS; GALLERIES; LARGE UNDERGROUND CHAMBERS
    • E21D11/00—Lining tunnels, galleries or other underground cavities, e.g. large underground chambers; Linings therefor; Making such linings in situ, e.g. by assembling
    • E21D11/14—Lining predominantly with metal
    • E21D11/28—Longitudinal struts, i.e. longitudinal connections between adjoining arches

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mining & Mineral Resources (AREA)
  • Epidemiology (AREA)
  • Civil Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Architecture (AREA)
  • Animal Behavior & Ethology (AREA)
  • Structural Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Geology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI680234A 1967-02-03 1968-01-30 Menetelmä matolääkkeinä vaikuttavien 5-(substituoitu amino)-bentsimida tsolien valmistamiseksi. FI52859C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61374667A 1967-02-03 1967-02-03
US69649668A 1968-01-09 1968-01-09

Publications (2)

Publication Number Publication Date
FI52859B FI52859B (enExample) 1977-08-31
FI52859C true FI52859C (fi) 1977-12-12

Family

ID=27087090

Family Applications (1)

Application Number Title Priority Date Filing Date
FI680234A FI52859C (fi) 1967-02-03 1968-01-30 Menetelmä matolääkkeinä vaikuttavien 5-(substituoitu amino)-bentsimida tsolien valmistamiseksi.

Country Status (19)

Country Link
AT (5) AT301244B (enExample)
BE (2) BE710081A (enExample)
CH (5) CH545796A (enExample)
CS (1) CS162651B2 (enExample)
CY (1) CY653A (enExample)
DE (2) DE1795711C3 (enExample)
DK (1) DK139940B (enExample)
ES (4) ES350083A1 (enExample)
FI (1) FI52859C (enExample)
FR (1) FR1580153A (enExample)
GB (2) GB1198942A (enExample)
IE (1) IE31812B1 (enExample)
IT (1) IT1044176B (enExample)
NL (1) NL157015B (enExample)
NO (1) NO126484B (enExample)
OA (1) OA04036A (enExample)
SE (1) SE346321B (enExample)
SU (1) SU540569A3 (enExample)
YU (1) YU33831B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711608A (en) * 1971-04-13 1973-01-16 Merck & Co Inc The treatment of pain, fever and inflammation with benzimidazoles
US3983130A (en) * 1972-06-02 1976-09-28 E. R. Squibb & Sons, Inc. Anthelmintic isothiocyanobenzoxazoles
US3985755A (en) * 1972-06-02 1976-10-12 E. R. Squibb & Sons, Inc. Pyridine containing isothiocyanobenzoxazoles
US3853894A (en) * 1972-06-02 1974-12-10 Squibb & Sons Inc Isothiocyanobenzimidazoles
MA19290A1 (fr) * 1980-05-22 1982-04-01 Ciba Geigy Ag Derives du benzole,leur preparaton et leur utilisations therapeutiques .
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
WO2004041277A1 (en) 2002-11-01 2004-05-21 Merck & Co., Inc. Carbonylamino-benzimidazole derivatives as androgen receptor modulators
EP1675844A1 (en) * 2003-10-23 2006-07-05 Sterix Limited Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
GB0324792D0 (en) 2003-10-23 2003-11-26 Sterix Ltd Compound
ATE435222T1 (de) * 2003-12-18 2009-07-15 Tibotec Pharm Ltd Aminobenzimidazole und benzimidazole als inhibitoren der replikation von respiratory syncytial virus
RU2410382C2 (ru) * 2005-03-17 2011-01-27 Тиботек Фармасьютикалз Лтд 1, 3-дигидробензимидазол-2-илиденовые амины в качестве ингибиторов репликации респираторного синцитиального вируса

Also Published As

Publication number Publication date
DE1695545A1 (de) 1971-05-06
ES363760A1 (es) 1970-12-16
AT289835B (de) 1971-05-10
IT1044176B (it) 1980-03-20
ES363761A1 (es) 1970-12-16
BE710081A (enExample) 1968-07-30
AT293378B (de) 1971-10-11
CY653A (en) 1972-08-31
DK139940C (enExample) 1979-10-15
CH545295A (de) 1974-01-31
CH509318A (de) 1971-06-30
DE1795711B2 (de) 1978-09-21
FI52859B (enExample) 1977-08-31
GB1198942A (en) 1970-07-15
AT289833B (de) 1971-05-10
ES363762A1 (es) 1970-12-16
IE31812L (en) 1968-08-03
OA04036A (fr) 1979-09-30
NL157015B (nl) 1978-06-15
CS162651B2 (enExample) 1975-07-15
DE1695545B2 (de) 1978-08-31
YU33831B (en) 1978-06-30
SU540569A3 (ru) 1976-12-25
IE31812B1 (en) 1973-01-10
YU21268A (en) 1977-12-31
FR1580153A (enExample) 1969-09-05
NO126484B (enExample) 1973-02-12
AT289828B (de) 1971-05-10
DE1795711C3 (de) 1979-05-17
DK139940B (da) 1979-05-21
DE1695545C3 (de) 1979-05-03
NL6801482A (enExample) 1968-08-05
CH545294A (de) 1974-01-31
GB1198941A (en) 1970-07-15
CH545796A (enExample) 1974-02-15
BE735281A (enExample) 1969-12-29
CH545293A (de) 1974-01-31
ES350083A1 (es) 1969-11-16
AT301244B (de) 1972-08-25
SE346321B (enExample) 1972-07-03
DE1795711A1 (de) 1974-02-28

Similar Documents

Publication Publication Date Title
DK137854B (da) Analogifremgangsmåde til fremstilling af 2-nitroimidazolderivater.
FI47153C (fi) Kiinteä seos steriloivan liuoksen valmistusta varten.
FI49298C (fi) Menetelmä masennuslääkkeenä käytettävien 3-aryylioksimetyylipiperidiin ijohdannaisten valmistamiseksi.
FI49716C (fi) Menetelmä 2,4-diamino-5-bentsyyli-pyrimidiinien valmistamiseksi.
FI48746C (fi) Menetelmä tetrapolymeerilateksin valmistamiseksi.
FI50334C (fi) Menetelmä 1-hydroksi-2pyridonien valmistamiseksi.
FI47575C (fi) Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi.
FI52216C (fi) Menetelmä gamma-piperidinobutyrofenonijohdannaisten valmistamiseksi.
FI47577C (fi) Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä.
FI50977C (fi) Menetelmä 7-kloori-5-fenyyli-1,4-bentsodiatsepiinien valmistamiseksi.
FI50975C (fi) Menetelmä pyratsiiniamidi-johdannaisten valmistamiseksi.
FI47576C (fi) Menetelmä 2-alkyyliamino-5-fenyyli-3H-1,4-bentsodiatsepiini-4-oksidien valmistamiseksi.
FI48088C (fi) Menetelmä 5-fenyyli-1H-1,4-bentsodiatsepiini-johdannaisten valmistamis eksi
FI46727C (fi) Menetelmä pyridatsolijohdannaisten valmistamiseksi.
FI52088C (fi) Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi.
FI47349C (fi) Menetelmä 17alfa-propadienyyli-17beta-hydroksi-steroidien valmistamise ksi.
FI51814C (fi) Menetelmä alfa-karboksibentsyylipenisiliinin kielteisen alkalimetallis uolojen valmistamiseksi.
FI46722C (fi) Menetelmä 1alfa-hydroksi-18-metyyli-5alfa-H-androstaanijohdannaisten v almistamiseksi.
FI48469C (fi) Menetelmä 1,4-bentsodiatsepiinijohdannaisten valmistamiseksi.
FI48835C (fi) Menetelmä matolääkkeenä käytettävien beta,beta,beta-trikloorietylideen ijohdannaisten valmistamiseksi.
FI48470C (fi) Menetelmä 2-animo-2H-1,4-bentsodiatsepiinijohdannaisten valmistamiseks i.
FI51544C (fi) Menetelmä makeutusaineseosten valmistamiseksi.
FI49412C (fi) Menetelmä substituoitujen 3-amino-sydnoni-imiinien valmistamiseksi.
FI45046C (fi) Menetelmä rauhoittavina aineina vaikuttavien fentiatsiinien 3,8-diatsa bisyklo-oktaani-johdannaisten valmistamiseksi.
FI51356C (fi) Menetelmä cis-propenyylifosfonihapon valmistamiseksi.